Clinical Trial Update: Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 study of AZD9574 as a monotherapy and in combination with anti-cancer agents is underway in participants with advanced solid malignancies, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AZD9574

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Solid Malignancies | Phase 1, Phase 2 | Status: RECRUITING